AIMCOPEST Aimco Pesticides Q4 FY25 results (Jan–Mar 2025) and concall
AIMCOPEST faced a challenging FY25 with flat top-line and negative PAT, primarily due to intense price competition and lower realizations in its active ingredient division, despite strong volume growth. The brand business, however, showed resilience with 15% growth. The company is focusing on new product development, international registrations in Brazil, and cost management to return to profitability in FY26, targeting ₹225 crores in sales and 20% growth in its formulation business.
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
What they filed
| Line item | Q2 FY25 | Q3 FY25 | Q4 FY25 |
|---|---|---|---|
| Revenue | 55 | 51 | 53 |
| EBITDA | 0 | 2 | -5 |
| Net profit | -1 | 0 | -5 |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.
